发明名称 RECOMBINANT ADENOVIRAL VECTOR AND METHOD OF USE
摘要 <P>PROBLEM TO BE SOLVED: To provide a vector and a method which give a high level of gene introduction efficiency and protein expression in order to provide a safe and effective gene therapy. <P>SOLUTION: A pharmaceutical composition comprises a recombinant adenovirus expression vector, and the recombinant adenovirus expression vector further comprises a pharmaceutical composition including genes including a partially or totally depleted protein IX DNA and a foreign protein. In one aspect, the depletion of the protein IX gene sequence expands from about 3,500 bp of the 5' virus end to about 4,000 bp of the 5' virus end. In another embodiment, the latter pharmaceutical composition further comprises depletion of a non-essential DNA sequence in initial region 3 and/or initial region 4 of adenovirus. <P>COPYRIGHT: (C)2010,JPO&INPIT
申请公布号 JP2009256370(A) 申请公布日期 2009.11.05
申请号 JP20090177086 申请日期 2009.07.29
申请人 CANJI INC 发明人 GREGORY RICHARD J;WILLS KEN N;MANEVAL DANIEL C
分类号 A61K35/76;C12N15/09;A61K31/522;A61K31/70;A61K31/7076;A61K31/7088;A61K38/00;A61K48/00;A61P35/00;A61P35/02;C07H21/04;C07K14/47;C12N5/10;C12N7/00;C12N15/861 主分类号 A61K35/76
代理机构 代理人
主权项
地址